OECD Acceptance Benefits Brazil's Economy
The acceptance of Brazilian medical device tests by the Organization for Economic Cooperation and Development (OECD) brings significant benefits to Brazil's economy and international trade. Under this mutual acceptance of laboratory data (MAD), the OECD recognizes tests conducted in Brazilian facilities compliant with Good Laboratory Practice (GLP) principles. This recognition reduces trade barriers, increases confidence in imports and exports, eliminates duplicative testing, minimizes animal testing, saves time and costs, and promotes harmonization in regulatory processes.
Strengthening Brazil's Position in Trade
Brazil's National Institute of Metrology, Quality, and Technology (Inmetro) has 50 GLP-compliant test facilities, strengthening Brazil's position in international trade. The initial agreement between Brazil and the OECD focused on pesticides and industrial chemical substances. Over time, the scope expanded to include various sectors, including veterinary products, cosmetics, pharmaceuticals, and now medical devices.
Commitment to International Standards
This expansion demonstrates Brazil's commitment to international standards and will be significant for Brazil's medical device industry. It strengthens Brazil's position in international trade, promotes economic growth, streamlines regulatory processes, and enhances the competitiveness of Brazilian medical device manufacturers in global markets.